WILD 5 Wellness, A 30-Day Intervention

WILD 5 Wellness, A 30 Day Intervention in First Year Students at Beloit College

The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition in First Year Beloit College students self-selected into a wellness focused first year initiative. This program is called "WILD 5 Wellness: A 30-Day Intervention".

Study Overview

• Status: Completed
• Conditions: Depression; Anxiety; Wellness; Cognitive Functioning
• Intervention / Treatment: Behavioral: WILD 5 Wellness Intervention

• Study Type: Interventional
• Enrollment (Actual): 33
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Wisconsin
    • Beloit, Wisconsin, United States, 53511
      • Beloit College

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 17 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Students 18 years of age or older or 17 years of age with legal guardian written permission.
• Students enrolled in First Year Initiative Courses titled "Balance" or "Constructing Health"

Exclusion Criteria:

• Individuals who are pregnant or plan to get pregnant during the next 30 days.
• Students who are not enrolled in the First Year Initiative Courses titled "Balance" or "Constructing Health"

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: First Year Students in Wellness FYIs	Behavioral: WILD 5 Wellness Intervention; Behaviors in 6 areas of wellness: Sleep, Social Connectedness, Exercise, Nutrition, Mindfulness and "HERO" (Happiness, Enthusiasm, Resilience, Optimism)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Patient Health Questionnaire-9 (PHQ-9)	PHQ-9 is a self reported depression scale. It is a 9-item scale with scores ranging from 0-27. Lower scores denote improvement.	Day 0, Day 30+ 3 days (approximately)
Change in Generalized Anxiety Disorder-7 (GAD-7)	GAD-7 is a self-reported questionnaire used to assess anxiety symptoms. It is a 7-item scale with scores ranging from 0-21. Lower score denotes improvement.	Day 0, Day 30+ 3 days (approximately)
Change in the HERO Wellness Scale	HERO Wellness Scale is a brief scale designed to measure mental wellness specifically happiness, enthusiasm, resilience and optimism. It is a 5-item scale with scores ranging from 0-10. Higher score denotes improvement.	Day 0, Day 30+ 3 days (approximately)
Change in World Health Organization-5 (WHO-5)	WHO-5 is a brief scale that measures mental well-being. It is a 5-item scale with scores ranging from 0-25. Higher score denotes improvement.	Day 0, Day 30+ 3 days (approximately)
Change in Cognitive and Physical Functioning Questionnaire (CPFQ)	CPFQ is a brief scale that measures cognitive and executive dysfunction. It is a 7-item scale with scores ranging from 7-42. Lower score denotes improvement.	Day 0, Day 30+ 3 days (approximately)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Post-Program Participant Questionnaire	The Post-Program Participant Questionnaire is a brief survey that captures participants'opinions about WILD 5 Wellness.	Day 30+ 3 days (approximately)

Collaborators and Investigators

• Sponsor: Beloit College
• Investigators: Principal Investigator: Tara M Girard, BSN, Beloit College; Principal Investigator: Suzanne Cox, PhD, Beloit College; Principal Investigator: Laura Parmentier, PhD, Beloit College; Principal Investigator: Saundra Jain, PsyD, LPC, Beloit College; Principal Investigator: Rakesh Jain, MD, MPH, Beloit College

Study record dates

Study Major Dates

• Study Start (Actual): October 24, 2017
• Primary Completion (Actual): November 29, 2017
• Study Completion (Actual): November 29, 2017

Study Registration Dates

• First Submitted: October 20, 2017
• First Submitted That Met QC Criteria: October 30, 2017
• First Posted (Actual): November 1, 2017

Study Record Updates

• Last Update Posted (Actual): April 26, 2018
• Last Update Submitted That Met QC Criteria: April 24, 2018
• Last Verified: April 1, 2018

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Depression
• Other Study ID Numbers: 374

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No